At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 120 enrolled
Drug / intervention
Systematic Screening and Education Regimenbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Bladder Management in Patients With Multiple Sclerosis: Optimizing Practice Patterns
In Brief
A Phase 4 clinical trial evaluating Systematic Screening and Education Regimen for Multiple Sclerosis and Urinary Bladder Diseases. Completed, enrolled 120 participants across 1 site.
Detailed Summary
This study will assess the impact of a systematic bladder health screening and disease education regimen as well as the implementation of a referral process on the quality of life of multiple sclerosis patients with bladder dysfunction.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMultiple Sclerosis, Urinary Bladder Diseases
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartAug 2013
First PostedAug 2013
Primary CompletionMar 2015
TodayJul 2026
First PostedAug 29, 2013
Enrollment StartAug 1, 2013
Primary CompletionMar 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 12.8 years ago
Interventions
Systematic Screening and Education Regimenbehavioral
Site will implement a systematic approach to screening bladder health dysfunction in multiple sclerosis patients, providing bladder health management education, and initiating appropriate urologist referrals.